-
PetMed Express reports $227 million in sales, $6.3 million net loss
-
PetMed Express receives nasdaq notice over delayed financial filings
-
PetMed Express (PETS) Receives Nasdaq Non-compliance Notice
-
PetMed Express (PETS) Provides Update on Status of Q4 and FY 2025 Results and Form 10-K Filing
-
PetMed Express (PETS) Reports Prelim Q4
-
PetMed Express (PETS) Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call
-
PetMed Express (PETS) and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets
-
PetMed Express (PETS) PT Lowered to $3.20 at Morgan Stanley
-
PetMed Express (PETS) Announces Appointment of Peter Batushansky to Board of Directors
-
PetMed Express (PETS) Misses Q3 EPS by 2c
-
PetMed Express (PETS) Adopts Limited Duration Shareholder Rights Plan
-
PetMed Express (PETS) Tops Q2 EPS by 15c
-
PetMed Express (PETS) Appoints Robyn D’Elia as CFO
-
Lake Street Capital Markets Downgrades PetMed Express (PETS) to Hold
-
PetMed Express (PETS) Tops Q1 EPS by 21c
-
PetMed Express (PETS) Appoints Doug Krulik as Chief Accounting Officer
-
Chewy (CHWY) Resumes Trading Now, Up 33% After Roaring Kitty Posts Image of Dog on X
-
PetMed Express (PETS) Appoints Leah Solivan to its Board
-
PetMed Express (PETS) PT Lowered to $7 at Lake Street Capital Markets
-
PetMed Express (PETS) Misses Q4 EPS by 24c

